These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An in vivo and in vitro evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine: an inhibitor of human lymphoblast purine nucleoside phosphorylase. Willis RC, Robins RK, Seegmiller JE. Mol Pharmacol; 1980 Sep 01; 18(2):287-95. PubMed ID: 6106888 [No Abstract] [Full Text] [Related]
13. Inactivation of purine nucleoside phosphorylase by modification of arginine residues. Jordan F, Wu A. Arch Biochem Biophys; 1978 Oct 01; 190(2):699-704. PubMed ID: 102259 [No Abstract] [Full Text] [Related]
19. Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts. Kazmers IS, Mitchell BS, Dadonna PE, Wotring LL, Townsend LB, Kelley WN. Science; 1981 Dec 04; 214(4525):1137-9. PubMed ID: 6795718 [Abstract] [Full Text] [Related]
20. Synthesis of 9-(3,4-dioxopentyl)hypoxanthine, the first arginine-directed purine derivative: an irreversible inactivator for purine nucleoside phosphorylase. Salamone SJ, Jordan F. Biochemistry; 1982 Dec 07; 21(25):6383-8. PubMed ID: 6817790 [Abstract] [Full Text] [Related] Page: [Next] [New Search]